Accordingly, although arthritis in Il17ra−/− mice was attenuated in all phases, the more pronounced clinical difference was found in the second phase of arthritis when the arthritis is amplified and maintained by CXCR2 chemokine ligands. The gene discussed is IL17RA; the disease is arthritic joint disease.